A Phase 1, Single and Multiple Dose Study of TAK-137

NCT02322606 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda